Persistent Asset Partners »

Cytomx Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 801 17.50
2025-09-30 $136k 43k 3.19

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
Bank of America Corporation
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Vanguard Group
Point72 Asset Management
Citadel Advisors
BlackRock
State Street Corporation
Baker Bros. Advisors
Elmind Capital
Nextech Invest
Financial Engines Advisors L.L.C

View all funds holding Cytomx Therapeutics